Cerevel Therapeutics Holdings Inc Stock Ownership - Who owns Cerevel Therapeutics Holdings?

Insider buying vs selling

Have Cerevel Therapeutics Holdings Inc insiders been buying or selling?
Scott AkamineChief Legal Officer2023-12-0710,000$13.17
Scott AkamineChief Legal Officer2023-12-0710,000$41.37
Scott AkamineChief Legal Officer2023-12-057,500$13.17
Scott AkamineChief Legal Officer2023-12-057,500$35.00
N. Anthony ColesDirector2023-11-1422,824$25.13
N. Anthony ColesDirector2023-11-1422,824$3.50
N. Anthony ColesDirector2023-11-08100$3.50
N. Anthony ColesDirector2023-11-08100$25.16
N. Anthony ColesDirector2023-11-0727,076$25.02
N. Anthony ColesDirector2023-11-0727,076$3.50

1 of 5

CERE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CERE insiders and whales buy or sell their stock.

CERE Shareholders

What type of owners hold Cerevel Therapeutics Holdings Inc stock?
Christopher R. Gordon70.07%126,315,419$5.21BInsider
Adam Koppel70.07%126,315,419$5.21BInsider
Bain Capital Investors LLC70.07%126,312,137$5.21BInsider
Bain Capital Investors LLC33.39%60,199,729$2.48BInstitution
Pfizer Inc14.50%26,149,211$1.08BInsider
Fmr LLC13.10%23,623,144$973.75MInstitution
Perceptive Advisors LLC5.60%10,088,385$415.84MInstitution
Vanguard Group Inc3.53%6,371,376$262.63MInstitution
Price T Rowe Associates Inc3.05%5,503,498$226.85MInstitution
Blackrock Inc2.77%4,991,026$205.73MInstitution

1 of 3

CERE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CERE25.60%74.40%Net BuyingNet Buying
APLS74.81%25.19%Net BuyingNet Selling
JAZZ26.62%73.38%Net SellingNet Selling
KRTX80.07%19.93%Net BuyingNet Buying
IMGN91.66%3.03%Net BuyingNet Selling

Cerevel Therapeutics Holdings Stock Ownership FAQ

Who owns Cerevel Therapeutics Holdings?

Cerevel Therapeutics Holdings (NASDAQ: CERE) is owned by 77.78% institutional shareholders, 226.02% Cerevel Therapeutics Holdings insiders, and 0.00% retail investors. Christopher R. Gordon is the largest individual Cerevel Therapeutics Holdings shareholder, owning 126.32M shares representing 70.07% of the company. Christopher R. Gordon's Cerevel Therapeutics Holdings shares are currently valued at $5.21B.

If you're new to stock investing, here's how to buy Cerevel Therapeutics Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.